Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies

Thorax

Volumn 68, Issue 2, 2013, Pages 171-176

  Seminog, Olena O ^a   Goldacre, Michael J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BIPOLAR DISORDER; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 84872679991     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202480     Document Type: Article

References (31)

1. Copeland LA, Mortensen EM, Zeber JE, et al. Pulmonary disease among inpatient decedents: impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:720-6.
2. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010;16:217-25.
3. Reynolds JH, McDonald G, Alton H, et al. Pneumonia in the immunocompetent patient. Br J Radiol 2010;83:998-1009.
4. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002;2:721-36.
5. Department of Health. Chapter 25. Pneumococcal. immunisation against infectious disease 2006. In: The Green Book. London: Department of Health, 2010. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/prod-consum-dh/ groups/dh-digitalassets/@dh/@en/documents/digitalasset/dh-122639.pdf (accessed 14 Jun 2012).
6. Centers for Disease Control and Prevention. Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23). Atlanta, Georgia: Centers for Disease Control and Prevention, 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5934a3.htm (accessed 14 Jun 2012).
7. Gill L, Goldacre M, Simmons H, et al. Computerised linking of medical records: methodological guidelines. J Epidemiol Community Health 1993;47:316-19.
8. Goldacre M, Kurina L, Yeates D, et al. Use of large medical databases to study associations between diseases. QJM 2000;93:669-75.
9. Melegaro A, Edmunds WJ, Pebody R, et al. The current burden of pneumococcal disease in England and Wales. J Infect 2006;52:37-48.
10. Goldacre MJ, Wotton CJ, Yeates D, et al. Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatry Psychiatr Epidemiol 2007;42:683-9.
11. Breslow N, Day N. Statistical Methods: in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer, 1987: 93-5.
12. Goff DC, Cather C, Evins AE, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry 2005;66:183-94.
13. Brown S, Mitchell C. Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort. Soc Psychiatry Psychiatr Epidemiol 2012;47:843-7.
14. Martens WH. A review of physical and mental health in homeless persons. Public Health Rev 2001;29:13-33.
15. Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008;10:1691-715.
16. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 2009;9:285.
17. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990;264:2511-18.
18. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007;64:566-76.
19. Almirall J, González CA, Balanzó X, et al. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999;116:375-9.
20. Raasch CE, Zhang P, Siggins RW II, et al. Acute alcohol intoxication impairs the hematopoietic precursor cell response to pneumococcal pneumonia. Alcohol Clin Exp Res 2010;34:2035-43.
21. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 2004;192:421-7.
22. Pedrelli P, McQuaid JR, Granholm E, et al. Measuring cognitive insight in middle-aged and older patients with psychotic disorders. Schizophr Res 2004;71:297-305.
23. Chen YH, Lin HC, Lin HC. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2011;37:1088-94.
24. Murakami H, Tamasawa N, Yamashita M, et al. Altered pain perception in schizophrenia. Lancet 2010;375:864.
25. Rosenthal SH, Porter KA, Coffey B. Pain insensitivity in schizophrenia. Case report and review of the literature. Gen Hosp Psychiatry 1990;12:319-22.
26. Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996;169:483-8.
27. Oyesanmi O, Kunkel EJ, Monti DA, et al. Hematologic side effects of psychotropics. Psychosomatics 1999;40:414-21.
28. Demler TL, Trigoboff E. Are clozapine blood dyscrasias associated with concomitant medications? Innov Clin Neurosci 2011;8:35-41.
29. Wilcox PG, Bassett A, Jones B, et al. Respiratory dysrhythmias in patients with tardive dyskinesia. Chest 1994;105:203-7.
30. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
31. Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009;180:48-58.